OPTICROM
LOE ApproachingNDAOPHTHALMICSOLUTION/DROPS
Approved
Oct 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 22h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OPTICROM is an ophthalmic solution approved in 1984 for topical ocular use. The specific indication and mechanism of action are not disclosed in available data. It is a small-molecule eye drop formulation.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating transitional portfolio status with likely reduced team investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
OPTICROM currently has zero linked job openings, reflecting its mature, LOE-approaching status. Career opportunities are limited to defensive portfolio management roles rather than growth-focused positions.
Brand ManagerField Sales Representative
Worked on OPTICROM at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.